TORONTO, ONTARIO--(Marketwire - April 14, 2010) - Dr. Anatoly Langer, the Chairman of CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company"), today announced that he acquired (1) ownership of 750,000 common shares of the Company and control or direction over 375,000 common shares of the Company, issued at a price of $0.05 per share pursuant to section 2.14 of National Instrument 45-106 – Prospectus and Registration Exemptions, as compensation for management services provided to the Company in the fourth quarter of 2009; and (2) 10,000,000 common shares of the Company and 10,000,000 common share purchase warrants of the Company (each warrant exercisable for two years for an additional share at a price of $0.10), issued at a price of $0.05 per unit (each unit comprised of one share and one warrant) pursuant to section 2.5(1) of National Instrument 45-106 – Prospectus and Registration Exemptions, under a non-brokered private placement. In the aggregate, the shares received by Dr. Langer represent approximately 18.2% of the issued and outstanding common shares of the Company.
Dr. Langer now owns or has control or direction over an aggregate of 30,923,081 common shares of the Company, representing approximately 50.7% of the Company's issued and outstanding common shares. In the future, Dr. Langer may receive further shares from the Company as compensation for the provision of management services. In addition, Dr. Langer has previously purchased shares from the Company for investment purposes, and in the future may further purchase, hold, vote, trade, dispose or otherwise deal in the common shares of the Company in such manner as he deems advisable to benefit from changes in market prices of such common shares, changes in the operations of the Company, its business strategy or prospects, or from a sale or merger of the Company.
Dr. Anatoly Langer
To review the report associated with this news release, please go to CardioComm's profile on SEDAR at www.sedar.com or contact CardioComm at 1.800.725.6585, ext. 264.